Naldemedine is efficacious for preventing opioid-induced constipation and for improving QOL among individuals with cancer.

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Constipation, or trouble using the bathroom, happens to just about everyone at some point or another. Unfortunately, because it’s such a universal affliction with so many sources, it can be ...

Some laxatives that can be used for constipation caused by MS include ... which will lead to a higher quality of life. A Word From Verywell The list of medications can be daunting, but know that ...

Participants in clinical trials reported higher levels of nausea, vomiting and constipation than in a placebo group ... He ...

This aversion can significantly impact their overall well-being, demonstrating just how powerful and consuming phobias can be ...

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...

KarXT — now with the brand name Cobenfy— is expected to be available in October with a list price of about $22,500 annually.